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A b s T r A C T
Two outbreaks of Q fever were reported in the Netherlands 
in 2007 and 2008. The ongoing 2008 outbreak in the 
south-eastern part of the Netherlands is the largest 
community outbreak ever described, with 808 cases 
reported until August 2008. The changing epidemiology 
of Q fever is most likely related to intensive goat farming, 
and has important implications for the clinical care of 
patients in endemic areas. Treatment of community-
acquired pneumonia has to take possible Q fever into 
account, and the high incidence of Q fever endocarditis and 
other manifestations of chronic Q fever require a specific 
diagnostic and therapeutic approach.
i N T r o d U C T i o N
In 2007, an outbreak of Q fever was reported in the 
Netherlands, in particular around the town of Herpen. 
In 2008, a remarkable further increase in Q fever cases 
was noted around the city of Nijmegen, in the provinces 
of Noord-Brabant and Gelderland, causing considerable 
morbidity and a high number of hospital admissions. Until 
13 August 2008, 808 cases were notified, constituting the 
largest community outbreak of Q fever reported in the 
literature.1
Q fever is an ubiquitous zoonosis, caused by Coxiella 
burnetii, an obligate intracellular coccobacillus. Q stands for 
query, dating from the period when the causative agent was 
still unknown. The first confirmed cases were described 
in 1937 as a febrile illness in abattoir workers in Brisbane, 
Australia. Subsequently, the pathogen was isolated by 
Cox and Davis from ticks in Montana and by Burnet from 
Derrick’s patients, and named Coxiella burnetii.
A C U T E  i l l N E s s
The incubation period varies from two to six weeks, 
depending on the infective dose. Most cases are 
asymptomatic (60%) or have mild flu-like symptoms. Only 
20% of infected patients seek medical attention, and 2 to 
3% are admitted to a hospital. The mortality rate is 1 to 2%.2 
Symptomatic patients present with a sudden onset of high 
fever, chills, severe headache and dyspnoea. Laboratory 
results show acute-phase reaction and often mild hepatitis. 
Chest X-rays usually reveal nonspecific infiltrates.3 In some 
patients, the clinical course is complicated by pericarditis, 
myocarditis, pancreatitis or haemolytic anaemia. The 
recent epidemic around Nijmegen has led to a considerable 
number of hospital admissions, including patients in need 
of intensive care and ventilatory assistance.
C H r o N i C  Q  f E V E r
A small proportion of infected patients develop chronic 
Q fever. Endocarditis is the most frequent manifestation, 
occurring in approximately 1% of patients following Q 
fever.4 Conversely, Q fever represents 3 to 5% of all cases 
of endocarditis.5 Q fever endocarditis usually occurs in 
patients with preexisting valvulopathy. Echocardiography 
reveals vegetations in only a small percentage of these 
patients, which makes diagnosis difficult. Modified Duke 
criteria have been developed for the diagnosis of Q fever 
endocarditis.6 Recent data suggest that endocarditis may 
develop in up to 40% of patients with pre-existing valvular 
defects.4 Graft infection may occur in patients with vascular 
prostheses. A high level of suspicion is crucial to diagnose 
patients with possible vascular infection in endemic areas. 
Other factors predisposing to Q fever endocarditis are 
immunosuppression, pregnancy, liver cirrhosis or cancer. 
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Q  f E V E r  A N d  P r E G N A N C Y
Pregnant women are especially prone to infection with Q 
fever. Q fever infection during pregnancy is almost always 
asymptomatic, but may result in obstetric complications 
such as spontaneous abortion, intrauterine growth 
retardation, foetal and neonatal death, or premature delivery.7,8 
Complications have been described in over 80% of women 
with Q fever during pregnancy. This percentage seems to 
be markedly reduced in women receiving long-term therapy 
with cotrimoxazole, but still remains considerably high 
(44%).7 Adverse outcome of pregnancy occurs in particular 
after infection during the first trimester. In addition, 
pregnancy may lead to reactivation of previous infection. 
After infection during pregnancy, breast feeding is considered 
contraindicated. This has major consequences for mother and 
child. The recent epidemic has raised the question whether 
pregnant women living in areas with high incidence of Q 
fever should be offered screening for Q fever.
l o N G - T E r M  s E Q U E l A E
Following acute infection with Q fever, patients frequently 
report long-lasting fatigue, often for more than six months. Ten 
years’ follow-up of patients after an outbreak in the UK revealed 
a high percentage of persisting fatigue, with almost 20% of 
patients fulfilling the criteria of chronic fatigue syndrome at 
ten years after acute infection, compared with 5% in controls.9 
In Australia, courts have granted large compensation for 
abattoir employees with chronic fatigue syndrome. Chronic 
fatigue after acute Q fever infection may be reported more 
frequently in the Netherlands following the recent epidemic 
and will result in considerable costs for the society.
d i A G N o s i s  o f  Q  f E V E r
Serology is the most important diagnostic tool for Q fever. 
Indirect immunofluorescence (IF) is the reference method.5 
Complement fixation is also available, but more laborious and 
less specific and sensitive than IF. Serological cross reactions 
with other micro-organisms occur, including Legionella 
and Leptospira species. Coxiella burnetii displays a unique 
antigenic variance in surface polysaccharides, which can be 
used to distinguish between acute and chronic infection. In 
acute infection, phase 2 antibodies develop, whereas chronic 
infection is characterised by high titres of phase 1 antibodies. 
Polymerase chain reaction (PCR) is highly specific and, 
although still in an experimental phase, can be useful in 
early diagnosis, since antibody response may not develop 
until a few weeks after onset of symptoms. It can become 
positive again in chronic Q fever. Culture of C. burnetii is 
difficult, as it is an obligate intracellular bacterium. Special 
precautions need to be taken because of high infectivity and 
handling is restricted to specialised laboratories.
E P i d E M i o l o G Y
The most important reservoir is formed by sheep, goats 
and cattle. Domestic animals such as dogs, cats, rabbits and 
birds can also carry the disease. Ticks are thought to spread 
the disease among animals. Infected animals excrete the 
bacteria in milk, faeces, urine, and in high concentrations 
in amniotic fluid and the placenta. The animals are often 
asymptomatic except for increased incidence of spontaneous 
abortion. Infection in humans occurs through inhalation of 
contaminated aerosols or ingestion of unpasteurised milk. 
Coxiella is resistant to chemical and physical desinfectants. 
A small inoculum is sufficient to cause clinical illness. 
Human-to-human transmission does not usually occur, 
although it has been described following contact with 
infected parturient women. 
A sero-epidemiological survey in the Netherlands performed 
in 1983 using immunofluorescence showed a seroprevalence 
of 24% in blood donors and 84% in veterinarians.10 Results 
of serosurveillance as part of a case-control study during the 
2007 outbreak around the town of Herpen have not yet been 
published. Until 2007, 10 to 20 cases of Coxiella infection 
were reported to the health authorities in the Netherlands 
each year, and no seasonal fluctuation was observed. These 
cases predominantly involved patients with occupational 
risk (farmers, veterinarians, slaughterhouse personnel). 
In 2007 a total of 167 cases were reported, most of whom 
had no occupational risk, but lived in a distinct area in 
the south-eastern part of the Netherlands. The outbreak 
correlated with the density of goat farms in this area, and 
the veterinary authorities had reported Q fever in local goat 
farms in 2006 and 2007.11 In 2007 and 2008, a seasonal 
variation has been observed with peak incidence from 
December to May, correlating with spread of manure from 
goat stables. In 2008, a marked increase in reported cases of 
Q fever has occurred. Since most patients are asymptomatic, 
the true number of infections is probably much higher than 
the more than 800 cases reported until now. Recently, a 
mandatory notification of Q fever in ruminants, including 
compatible symptoms, such as abortion, has been instituted. 
Also, restriction for visitors to infected farms and a ban on 
spreading manure for three months have been imposed.1
T r E A T M E N T
Increased awareness in areas with a high incidence of 
Q fever is crucial. Most patients with acute Q fever are 
asymptomatic or have only mild symptoms, and therefore 
will not seek medical attention. Patients presenting with 
Delsing, et al. Q fever in the Netherlands.
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acute illness should be treated with doxycycline 100 mg 
twice daily for two to three weeks. Antibiotic treatment 
shortens the duration of fever and accelerates the recovery 
in case of pneumonia.3 Treatment with fluoroquinolones 
is an alternative. Cotrimoxazole is advised for treatment 
of children. 
In endemic areas, these recommendations should overrule 
the standard guidelines for treatment of community-
acquired pneumonia, such as the national guidelines in 
the Netherlands issued by the Dutch Working Party on 
Antibiotic Policy (SWAB) and the Dutch College of General 
Practitioners (NHG), which do not routinely cover Coxiella 
burnetii in moderately ill patients.12 
Long-term treatment of endocarditis with combination 
therapy of doxycycline (100 mg twice daily) and 
hydroxychloroquine (200 mg twice daily) for at least 12 to 18 
months have yielded favourable results.13 Because of the high 
incidence of endocarditis following acute Q fever in patients 
with pre-existing valvulopathy, some experts recommend 
12 months of combination therapy with doxycycline and 
hydroxychloroquine for this selected group.4
Q fever during pregnancy is treated with long-term 
therapy with cotrimoxazole (960 mg twice daily), at least 
until delivery. Further treatment with doxycycline and 
hydroxychloroquine may prevent persistence of Q fever.8 
Mothers should be instructed to refrain from breast 
feeding, and serological screening is needed during 
subsequent pregnancies.
P r E V E N T i V E  M E A s U r E s
Effective vaccines have been developed but are currently 
not available in the Netherlands. Pregnant women are 
advised to avoid contact with cattle farms that are suspect 
of being infected with Q fever. 
A conference held by the Dutch Health Council and the 
National Institute for Public Health and Environment 
(RIVM) in July 2008, attended by international experts 
on the subject, addressed the usefulness of screening 
pregnant women for Q fever, and the possible transmission 
of Q fever by blood transfusion. It was concluded that 
the currently available diagnostic tests for Q fever are 
not suitable for screening of large groups. Moreover, the 
efficacy and possible disadvantages of long-term use of 
antibiotics is still unknown. Further epidemiological 
research of the risks of Q fever during pregnancy will 
be conducted. Based on international data, the risk of 
transmission by blood transfusion seems negligible and 
the policy for blood donors should not be changed. 
The necessity of taking further measures to prevent 
transmission of Q fever from animals to humans will 
be investigated. Since 12 June 2008, Q fever has been 
designated by the Dutch government to be a reportable 
disease in goats and sheep. Spread of manure of infected 
goat farms is prohibited for at least 90 days after suspicion 
of infection. 
C o N C l U s i o N s
Q fever is an emerging epidemic disease in the Netherlands 
with considerable morbidity and serious long-term 
complications. Further increase in reported cases is 
likely in the coming years. Physicians need to be aware 
of the increased incidence of chronic Q fever, and of the 
appropriate diagnostic procedures and empirical therapy. 
More effort will have to be taken to prevent infections. New 
guidelines for general practitioners and gynaecologists 
are under construction. When treating a community-
acquired pneumonia, a possible infection with Q fever 
should be taken into account, resulting in a deviation from 
the national SWAB treatment guidelines for community-
acquired pneumonia. 
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